Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Applied Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
APLT
Nasdaq
8731
https://www.appliedtherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Applied Therapeutics Inc
Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why
- Mar 13th, 2024 1:23 pm
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress
- Mar 8th, 2024 9:32 am
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
- Mar 6th, 2024 12:00 pm
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
- Feb 28th, 2024 6:01 pm
Applied Therapeutics Announces $100 Million Private Placement
- Feb 28th, 2024 1:05 pm
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
- Feb 28th, 2024 1:00 pm
13 Best Booming Stocks to Buy Right Now
- Feb 21st, 2024 2:21 pm
Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency
- Feb 15th, 2024 12:00 pm
We Think Applied Therapeutics (NASDAQ:APLT) Needs To Drive Business Growth Carefully
- Jan 18th, 2024 12:05 pm
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
- Jan 4th, 2024 9:05 pm
Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia
- Jan 3rd, 2024 12:00 pm
Applied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ...
- Nov 9th, 2023 1:34 pm
Applied Therapeutics Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 12:30 pm
Applied Therapeutics, Inc. (NASDAQ:APLT) is definitely on the radar of institutional investors who own 38% of the company
- Nov 5th, 2023 12:07 pm
Applied Therapeutics to Present at the UBS Biopharma Conference 2023
- Nov 2nd, 2023 11:00 am
Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7
- Nov 1st, 2023 11:00 am
12 Best Performing Biotech Stocks in 2023
- Oct 20th, 2023 5:22 pm
Applied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting
- Sep 28th, 2023 11:00 am
Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023
- Sep 6th, 2023 11:00 am
We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
- Aug 11th, 2023 11:42 am
Scroll